Report cover image

Precision Medicine Software Market Size, Share & Trends Analysis Report By Component (Software & Services), By Deployment (Cloud-Based, On Premise), By Application, By Technology, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2

Publisher Grand View Research
Published Oct 03, 2025
Length 100 Pages
SKU # GV20574969

Description

Precision Medicine Software Market Summary

The global precision medicine software market size was valued at USD 2.12 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 11.8% from 2025 to 2033. This growth is attributed to declining cost of genome sequencing, rise of targeted and personalized therapies, the increase of decentralized trials, and real-world evidence.

Moreover, government and institutional initiatives supporting genomics and precision medicine, and demand for personalized healthcare, have fueled the industry outlook. The declining cost of genome sequencing has transformed it from a high-cost, research-only tool into a routine part of clinical practice, making it a key driver of the precision medicine software industry. What once cost nearly USD 100 million per genome in the early 2000s can now be performed for under USD 500, enabling widespread adoption by hospitals, diagnostic labs, pharmaceutical companies, and even consumer health firms.

This affordability has led to a surge in large-scale genomic testing, generating massive datasets that require advanced software for storage, integration, and interpretation. Precision medicine software plays a central role in converting this raw sequencing data into actionable clinical insights for diagnosis, therapy selection, and patient stratification, driving demand as sequencing becomes standard in oncology, rare disease treatment, and preventive healthcare.

Global Precision Medicine Software Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global precision medicine software market report based on component, deployment mode, application, technology, therapeutic area, end use and region.
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Implementation & integration
  • Clinical interpretation & reporting services
  • Validation & regulatory support
  • Data curation / annotation services
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-based
  • On-premise
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Genomic Data Management & Analysis
  • Multi-omics Analytics
  • Clinical Decision Support & Treatment Planning
  • Companion Diagnostics & Biomarker Discovery Tools
  • Clinical Trial Matching & Site Selection
  • Others (Population Genomics / Public-health Precision Tools)
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • AI / Machine Learning models & Generative AI
  • Rule-based engines (clinical guidelines, pathways)
  • Cloud & Containerized Pipelines (Kubernetes/Docker)
  • High-performance compute / HPC for genomics
  • Interoperability / FHIR / HL7 integration
  • Others (Data lakes & MDM (multi-modal data stores))
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiology
  • Neurology / CNS
  • Rare & Genetic Disorders
  • Infectious Diseases (pathogen genomics)
  • Immunology / Autoimmune
  • Others (dermatology, endocrinology)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Pharmaceutical & Biotech companies
  • Diagnostic Laboratories & Genomic Service Providers
  • Contract Research Organizations (CROs)
  • Others (Research Institutes & Academic Centers)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Deployment Mode
1.2.3. Application
1.2.4. Technology
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Declining Cost of Genome Sequencing
3.2.1.2. Shift toward value-based and personalized care
3.2.1.3. Government and institutional initiatives supporting genomics and precision medicine
3.2.1.4. Rising patient awareness and demand for personalized healthcare
3.2.1.5. Maturing interoperability standards (FHIR, GA4GH, HL7)
3.2.1.6. Advances in AI and machine learning
3.2.2. Market Restraint Analysis
3.2.2.1. High implementation and maintenance costs
3.2.2.2. Integration challenges with legacy electronic health records
3.2.2.3. Shortage of skilled professionals in bioinformatics, genomics, and data science.
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Technology Overview
3.2.6. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Precision Medicine Software Market: Component Estimates & Trend Analysis
4.1. Component Segment Dashboard
4.2. Component Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Implementation & integration
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Clinical interpretation & reporting services
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Validation & regulatory support
4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Data curation / annotation services
4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Others
4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Precision Medicine Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Deployment Mode Dashboard
5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
5.4. Cloud Based
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. On-Premise
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Precision Medicine Software Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Application Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genomic Data Management & Analysis
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Multi-omics Analytics
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Clinical Decision Support & Treatment Planning
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Companion Diagnostics & Biomarker Discovery Tools
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Clinical Trial Matching & Site Selection
6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others (Population Genomics / Public-health Precision Tools)
6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Precision Medicine Software Market: Technology Estimates & Trend Analysis
7.1. Technology Dashboard
7.2. Technology Market Share Movement Analysis, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
7.4. AI / Machine Learning models & Generative AI
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Rule-based engines (clinical guidelines, pathways)
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Cloud & Containerized Pipelines (Kubernetes/Docker)
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. High-performance compute / HPC for genomics
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Interoperability / FHIR / HL7 integration
7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.9. Others (Data lakes & MDM (multi-modal data stores))
7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Precision Medicine Software Market: Therapeutic Area Estimates & Trend Analysis
8.1. Therapeutic Area Dashboard
8.2. Therapeutic Area Market Share Movement Analysis, 2024 & 2033
8.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
8.4. Oncology
8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Cardiology
8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Neurology / CNS
8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Rare & Genetic Disorders
8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Infectious Diseases (pathogen genomics)
8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.9. Immunology / Autoimmune
8.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.10. Others (dermatology, endocrinology)
8.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Precision Medicine Software Market: End Use Estimates & Trend Analysis
9.1. End Use Segment Dashboard
9.2. End Use Market Share Movement Analysis, 2024 & 2033
9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Pharmaceutical & Biotech companies
9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Diagnostic Laboratories & Genomic Service Providers
9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Contract Research Organizations (CROs)
9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Others (Research Institutes & Academic Centers)
9.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Precision Medicine Software Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market: Key Takeaways
10.3. North America
10.3.1. North America Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.2. U.S.
10.3.2.1. Key country dynamic
10.3.2.2. Regulatory framework
10.3.2.3. Competitive insights
10.3.2.4. U.S. Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.3. Canada
10.3.3.1. Key country dynamic
10.3.3.2. Regulatory framework
10.3.3.3. Competitive insights
10.3.3.4. Canada Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.4. Mexico
10.3.4.1. Key country dynamic
10.3.4.2. Regulatory framework
10.3.4.3. Competitive insights
10.3.4.4. Mexico Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4. Europe
10.4.1. Europe Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.2. Germany
10.4.2.1. Key country dynamic
10.4.2.2. Regulatory framework
10.4.2.3. Competitive insights
10.4.2.4. Germany Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.3. UK
10.4.3.1. Key country dynamic
10.4.3.2. Regulatory framework
10.4.3.3. Competitive insights
10.4.3.4. UK Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.4. France
10.4.4.1. Key country dynamic
10.4.4.2. Regulatory framework
10.4.4.3. Competitive insights
10.4.4.4. France Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.5. Italy
10.4.5.1. Key country dynamic
10.4.5.2. Regulatory framework
10.4.5.3. Competitive insights
10.4.5.4. Italy Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.6. Spain
10.4.6.1. Key country dynamic
10.4.6.2. Regulatory framework
10.4.6.3. Competitive insights
10.4.6.4. Spain Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.7. Denmark
10.4.7.1. Key country dynamic
10.4.7.2. Regulatory framework
10.4.7.3. Competitive insights
10.4.7.4. Denmark Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.8. Sweden
10.4.8.1. Key country dynamic
10.4.8.2. Regulatory framework
10.4.8.3. Competitive insights
10.4.8.4. Sweden Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.9. Norway
10.4.9.1. Key country dynamic
10.4.9.2. Regulatory framework
10.4.9.3. Competitive insights
10.4.9.4. Norway Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5. Asia Pacific
10.5.1. Asia Pacific Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.2. Japan
10.5.2.1. Key country dynamic
10.5.2.2. Regulatory framework
10.5.2.3. Competitive insights
10.5.2.4. Japan Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.3. China
10.5.3.1. Key country dynamic
10.5.3.2. Regulatory framework
10.5.3.3. Competitive insights
10.5.3.4. China Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.4. India
10.5.4.1. Key country dynamic
10.5.4.2. Regulatory framework
10.5.4.3. Competitive insights
10.5.4.4. India Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.5. South Korea
10.5.5.1. Key country dynamic
10.5.5.2. Regulatory framework
10.5.5.3. Competitive insights
10.5.5.4. South Korea Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.6. Australia
10.5.6.1. Key country dynamic
10.5.6.2. Regulatory framework
10.5.6.3. Competitive insights
10.5.6.4. Australia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.7. Thailand
10.5.7.1. Key country dynamic
10.5.7.2. Regulatory framework
10.5.7.3. Competitive insights
10.5.7.4. Thailand Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.6. Latin America
10.6.1. Latin America Precision Medicine Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.6.2. Brazil
10.6.2.1. Key country dynamic
10.6.2.2. Regulatory framework
10.6.2.3. Competitive insights
10.6.2.4. Brazil Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.6.3. Argentina
10.6.3.1. Key country dynamic
10.6.3.2. Regulatory framework
10.6.3.3. Competitive insights
10.6.3.4. Argentina Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7. MEA
10.7.1. MEA Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.2. South Africa
10.7.2.1. Key country dynamic
10.7.2.2. Regulatory framework
10.7.2.3. Competitive insights
10.7.2.4. South Africa Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key country dynamic
10.7.3.2. Regulatory framework
10.7.3.3. Competitive insights
10.7.3.4. Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.4. UAE
10.7.4.1. Key country dynamic
10.7.4.2. Regulatory framework
10.7.4.3. Competitive insights
10.7.4.4. UAE Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key country dynamic
10.7.5.2. Regulatory framework
10.7.5.3. Competitive insights
10.7.5.4. Kuwait Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Participant Overview
11.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
11.3. Company Categorization
11.4. Strategy Mapping
11.5. Company Profiles/Listing
11.5.1. OSP
11.5.1.1. Overview
11.5.1.2. Financial performance
11.5.1.3. Product benchmarking
11.5.1.4. Strategic initiatives
11.5.2. Genomind
11.5.2.1. Overview
11.5.2.2. Financial performance
11.5.2.3. Product benchmarking
11.5.2.4. Strategic initiatives
11.5.3. IQVIA
11.5.3.1. Overview
11.5.3.2. Financial performance
11.5.3.3. Product benchmarking
11.5.3.4. Strategic initiatives
11.5.4. Genedata AG
11.5.4.1. Overview
11.5.4.2. Financial performance
11.5.4.3. Product benchmarking
11.5.4.4. Strategic initiatives
11.5.5. SOPHiA GENETICS
11.5.5.1. Overview
11.5.5.2. Financial performance
11.5.5.3. Product benchmarking
11.5.5.4. Strategic initiatives
11.5.6. Tempus AI, Inc.
11.5.6.1. Overview
11.5.6.2. Financial performance
11.5.6.3. Product benchmarking
11.5.6.4. Strategic initiatives
11.5.7. Owkin, Inc.
11.5.7.1. Overview
11.5.7.2. Financial performance
11.5.7.3. Product benchmarking
11.5.7.4. Strategic initiatives
11.5.8. Syapse (acquired by N-Power in January 2025)
11.5.8.1. Overview
11.5.8.2. Financial performance
11.5.8.3. Product benchmarking
11.5.8.4. Strategic initiatives
11.5.9. Inspirata, Inc.
11.5.9.1. Overview
11.5.9.2. Financial performance
11.5.9.3. Product benchmarking
11.5.9.4. Strategic initiatives
11.5.10. Precision Medicine Group, LLC.
11.5.10.1. Overview
11.5.10.2. Financial performance
11.5.10.3. Product benchmarking
11.5.10.4. Strategic initiatives
11.5.11. Siemens
11.5.11.1. Overview
11.5.11.2. Financial performance
11.5.11.3. Product benchmarking
11.5.11.4. Strategic initiatives
11.5.12. GenomOncology LLC
11.5.12.1. Overview
11.5.12.2. Financial performance
11.5.12.3. Product benchmarking
11.5.12.4. Strategic initiatives
11.5.13. Qserve
11.5.13.1. Overview
11.5.13.2. Financial performance
11.5.13.3. Product benchmarking
11.5.13.4. Strategic initiatives
11.5.14. Foundation Medicine, Inc.
11.5.14.1. Overview
11.5.14.2. Financial performance
11.5.14.3. Product benchmarking
11.5.14.4. Strategic initiatives
11.5.15. PierianDx
11.5.15.1. Overview
11.5.15.2. Financial performance
11.5.15.3. Product benchmarking
11.5.15.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us